Search details
1.
Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer.
Int J Gynecol Cancer
; 2022 Jun 24.
Article
in English
| MEDLINE | ID: mdl-35750354
Results
1 -
1
de 1
1
Next >
>>